Milciclib: Initiation of P2b trial for HCC in Q3 2021 (Tiziana Life Sciences) - Jan 27, 2021 - Investor Presentation: Interim data from P2b trial for HCC in Q2 2022
New P2b trial • P2b data • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology
|